Your browser doesn't support javascript.
loading
Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growth.
Ma, Z; Wong, S W; Forgham, H; Esser, L; Lai, M; Leiske, M N; Kempe, K; Sharbeen, G; Youkhana, J; Mansfeld, F; Quinn, J F; Phillips, P A; Davis, T P; Kavallaris, M; McCarroll, J A.
Afiliação
  • Ma Z; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia; School of Women's and Children's Health, UNSW Sydney, Australia; Australian Centre for NanoMedicine, UNSW Sydney, Australia.
  • Wong SW; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.
  • Forgham H; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia; School of Women's and Children's Health, UNSW Sydney, Australia; Australian Centre for NanoMedicine, UNSW Sydney, Australia.
  • Esser L; Commonwealth Scientific and Industrial Research Organisation, Melbourne, Australia.
  • Lai M; Drug Delivery Disposition and Dynamics Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Australia.
  • Leiske MN; Drug Delivery Disposition and Dynamics Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Australia; Department of Organic and Macromolecular Chemistry, Ghent University, Krijgslaan, Belgium.
  • Kempe K; Drug Delivery Disposition and Dynamics Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Australia; Materials Science and Engineering, Monash University, Australia.
  • Sharbeen G; Pancreatic Cancer Translational Research Group, Adult Cancer Program, Lowy Cancer Research Centre, UNSW Sydney, Australia; School of Medical Sciences, Lowy Cancer Research Centre, UNSW Sydney, Australia.
  • Youkhana J; Pancreatic Cancer Translational Research Group, Adult Cancer Program, Lowy Cancer Research Centre, UNSW Sydney, Australia; School of Medical Sciences, Lowy Cancer Research Centre, UNSW Sydney, Australia.
  • Mansfeld F; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia; Australian Centre for NanoMedicine, UNSW Sydney, Australia; Commonwealth Scientific and Industrial Research Organisation, Melbourne, Australia.
  • Quinn JF; Drug Delivery Disposition and Dynamics Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Australia; Department of Chemical Engineering, Faculty of Engineering, Monash University, Australia.
  • Phillips PA; Australian Centre for NanoMedicine, UNSW Sydney, Australia; Pancreatic Cancer Translational Research Group, Adult Cancer Program, Lowy Cancer Research Centre, UNSW Sydney, Australia; School of Medical Sciences, Lowy Cancer Research Centre, UNSW Sydney, Australia.
  • Davis TP; Drug Delivery Disposition and Dynamics Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Australia; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Australia.
  • Kavallaris M; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia; School of Women's and Children's Health, UNSW Sydney, Australia; Australian Centre for NanoMedicine, UNSW Sydney, Australia; UNSW RNA Institute, Sydney, UNSW Sydney, Australia. Electronic address: mkavallaris@ccia.org.
  • McCarroll JA; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia; School of Women's and Children's Health, UNSW Sydney, Australia; Australian Centre for NanoMedicine, UNSW Sydney, Australia; UNSW RNA Institute, Sydney, UNSW Sydney, Australia. Electronic address: jmccarroll@ccia.org.a
Biomaterials ; 285: 121539, 2022 06.
Article em En | MEDLINE | ID: mdl-35500393

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article